Log in

NASDAQ:AQXPAquinox Pharmaceuticals Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$12.16
-0.08 (-0.65 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$11.95
Now: $12.16
$12.85
50-Day Range
$3.68
MA: $3.94
$4.03
52-Week Range
$2.00
Now: $12.16
$3.84
Volume247,121 shs
Average Volume239,362 shs
Market Capitalization$286.25 million
P/E RatioN/A
Dividend YieldN/A
Beta-7.37
Aquinox Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in developing novel therapeutics for chronic urological conditions by inflammation and pain. The company focuses on a library of novel compounds that activate SH2-containing inositol-5'-phosphatase 1 (SHIP1) to develop therapeutics for application in inflammation, inflammatory pain, and blood cancers. Its lead product candidate is Rosiptor (Leadership 301), a small molecule activator of SHIP1 that is in Phase III clinical trials for treatment in interstitial cystitis/bladder pain syndrome. The company was formerly known as Aquinox Pharmaceuticals (USA) Inc. and changed its name to Aquinox Pharmaceuticals, Inc. in January 2014. Aquinox Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.
Read More
Aquinox Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.76 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AQXP
CUSIPN/A
Phone604-629-9223

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$25 million
Book Value$3.09 per share

Profitability

Net Income$-31,580,000.00

Miscellaneous

Employees8
Market Cap$286.25 million
Next Earnings DateN/A
OptionableOptionable

Receive AQXP News and Ratings via Email

Sign-up to receive the latest news and ratings for AQXP and its competitors with MarketBeat's FREE daily newsletter.

Aquinox Pharmaceuticals (NASDAQ:AQXP) Frequently Asked Questions

How were Aquinox Pharmaceuticals' earnings last quarter?

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) announced its quarterly earnings data on Thursday, November, 8th. The company reported ($0.64) EPS for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.43. View Aquinox Pharmaceuticals' earnings history.

Has Aquinox Pharmaceuticals been receiving favorable news coverage?

Media coverage about AQXP stock has been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aquinox Pharmaceuticals earned a news sentiment score of -1.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutAquinox Pharmaceuticals.

Who are some of Aquinox Pharmaceuticals' key competitors?

What other stocks do shareholders of Aquinox Pharmaceuticals own?

Who are Aquinox Pharmaceuticals' key executives?

Aquinox Pharmaceuticals' management team includes the following people:
  • Mr. David J. Main, Co-Founder, Chairman, CEO & Pres (Age 54)
  • Mr. Kamran Alam, CFO, VP of Fin. & Corp. Sec. (Age 45)
  • Ms. Shelley McCloskey, VP of HR & Admin. (Age 59)

What is Aquinox Pharmaceuticals' stock symbol?

Aquinox Pharmaceuticals trades on the NASDAQ under the ticker symbol "AQXP."

What is Aquinox Pharmaceuticals' stock price today?

One share of AQXP stock can currently be purchased for approximately $12.16.

How big of a company is Aquinox Pharmaceuticals?

Aquinox Pharmaceuticals has a market capitalization of $286.25 million and generates $25 million in revenue each year. Aquinox Pharmaceuticals employs 8 workers across the globe.

What is Aquinox Pharmaceuticals' official website?

The official website for Aquinox Pharmaceuticals is www.aqxpharma.com.

How can I contact Aquinox Pharmaceuticals?

Aquinox Pharmaceuticals' mailing address is 450-887 GREAT NORTHERN WAY, VANCOUVER A1, V5T 4T5. The company can be reached via phone at 604-629-9223 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.